Adam I. Riker

6.4k total citations · 1 hit paper
100 papers, 4.4k citations indexed

About

Adam I. Riker is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Adam I. Riker has authored 100 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 46 papers in Oncology and 29 papers in Immunology. Recurrent topics in Adam I. Riker's work include Immunotherapy and Immune Responses (28 papers), CAR-T cell therapy research (14 papers) and Cutaneous Melanoma Detection and Management (12 papers). Adam I. Riker is often cited by papers focused on Immunotherapy and Immune Responses (28 papers), CAR-T cell therapy research (14 papers) and Cutaneous Melanoma Detection and Management (12 papers). Adam I. Riker collaborates with scholars based in United States, China and Norway. Adam I. Riker's co-authors include Øystein Fodstad, Yaguang Xi, Suhu Liu, Adil Daud, Jane L. Messina, Paul Howell, Francesco M. Marincola, Steven A. Rosenberg, Vernon K. Sondak and Suping Ren and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Adam I. Riker

97 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma

2008 503 citations Adil Daud, Ronald C. DeConti et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Adam I. Riker United States	35	2.2k	1.6k	1.4k	1.0k	455	100	4.4k
Yoshihiko Hirohashi Japan	40	2.5k 1.1×	2.2k 1.3×	1.9k 1.4×	739 0.7×	253 0.6×	217	4.8k
Hartmut Koeppen United States	30	3.5k 1.6×	3.0k 1.8×	1.9k 1.4×	992 1.0×	346 0.8×	62	6.4k
Klára Tótpál United States	29	3.5k 1.6×	1.7k 1.0×	2.1k 1.6×	642 0.6×	279 0.6×	59	5.3k
János L. Tanyi United States	36	1.9k 0.9×	1.7k 1.0×	887 0.6×	720 0.7×	144 0.3×	113	3.9k
Shawn G. Clouthier United States	29	2.2k 1.0×	2.1k 1.3×	1.2k 0.9×	1.1k 1.1×	130 0.3×	51	4.7k
Ann Zeuner Italy	35	2.4k 1.1×	1.4k 0.8×	879 0.6×	867 0.8×	154 0.3×	72	4.3k
Martin R. Sprick Germany	31	4.0k 1.8×	3.6k 2.2×	1.3k 0.9×	2.0k 2.0×	406 0.9×	58	6.6k
Kimberly R. Kalli United States	46	2.2k 1.0×	2.1k 1.3×	1.6k 1.2×	1.1k 1.1×	132 0.3×	101	5.5k
William E. Fogler United States	38	2.0k 0.9×	1.1k 0.6×	1.4k 1.0×	648 0.6×	282 0.6×	105	3.9k
Asís Palazón Spain	30	1.4k 0.6×	1.5k 0.9×	2.0k 1.4×	1.1k 1.1×	141 0.3×	53	4.0k

Countries citing papers authored by Adam I. Riker

Since Specialization

Citations

This map shows the geographic impact of Adam I. Riker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam I. Riker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam I. Riker more than expected).

Fields of papers citing papers by Adam I. Riker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam I. Riker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam I. Riker. The network helps show where Adam I. Riker may publish in the future.

Co-authorship network of co-authors of Adam I. Riker

This figure shows the co-authorship network connecting the top 25 collaborators of Adam I. Riker. A scholar is included among the top collaborators of Adam I. Riker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam I. Riker. Adam I. Riker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ma, Ruixia, et al.. (2025). Sulindac sulfide suppresses oncogenic transformation through let-7b-mediated repression of K-Ras signaling. Cell Death Discovery. 11(1). 530–530.

Kim, Emily, et al.. (2024). Male Breast Cancer With Dual BRCA2 and BRIP1 Deleterious Gene Mutations. Ochsner Journal. 24(2). 157–161.

Orr, James W., et al.. (2022). Improving Operating Room Efficiency: Relocating a Surgical Oncology Program Within a Health Care System. Ochsner Journal. 22(3). 230–238. 1 indexed citations

Yi, Bin, Hao Cheng, Dorota Wyczechowska, et al.. (2021). Sulindac Modulates the Response of Proficient MMR Colorectal Cancer to Anti–PD-L1 Immunotherapy. Molecular Cancer Therapeutics. 20(7). 1295–1304. 8 indexed citations

Riker, Adam I., et al.. (2021). Metastatic Papillary Thyroid Cancer to the Liver: The Central Role of a Multidisciplinary Approach to Treatment. Ochsner Journal. 21(2). 224–229. 2 indexed citations

Matossian, Margarite D., Steven Elliott, Hope E. Burks, et al.. (2020). Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor. PLoS ONE. 15(10). e0226464–e0226464. 13 indexed citations

Gao, Lin, Yanhui Gao, Zheng‐Xiang Li, et al.. (2011). Aquaporins mediate the chemoresistance of human melanoma cells to arsenite. Molecular Oncology. 6(1). 81–87. 42 indexed citations

Geng, Degui, Liqin Zheng, Ratika Srivastava, et al.. (2010). Amplifying TLR-MyD88 Signals within Tumor-Specific T Cells Enhances Antitumor Activity to Suboptimal Levels of Weakly Immunogenic Tumor Antigens. Cancer Research. 70(19). 7442–7454. 37 indexed citations

Zhou, Ming, Zixing Liu, Yuhua Zhao, et al.. (2010). MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression. Journal of Biological Chemistry. 285(28). 21496–21507. 347 indexed citations

10.

Metge, Brandon J., Suhu Liu, Adam I. Riker, et al.. (2010). Elevated Osteopontin Levels in Metastatic Melanoma Correlate with Epigenetic Silencing of Breast Cancer Metastasis Suppressor 1. Oncology. 78(1). 75–86. 15 indexed citations

11.

Ren, Suping, Suhu Liu, Paul Howell, et al.. (2009). Functional characterization of the progestagen‐associated endometrial protein gene in human melanoma. Journal of Cellular and Molecular Medicine. 14(6b). 1432–1442. 20 indexed citations

12.

Das, Shamik, Brandon J. Metge, Suhu Liu, et al.. (2009). The Hedgehog Pathway Transcription Factor GLI1 Promotes Malignant Behavior of Cancer Cells by Up-regulating Osteopontin. Journal of Biological Chemistry. 284(34). 22888–22897. 98 indexed citations

13.

Daud, Adil, Ronald C. DeConti, Stephanie Andrews, et al.. (2008). Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma. Journal of Clinical Oncology. 26(36). 5896–5903. 503 indexed citations breakdown →

14.

Liu, Suhu, Suping Ren, Paul Howell, Øystein Fodstad, & Adam I. Riker. (2008). Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling. Pigment Cell & Melanoma Research. 21(5). 545–558. 104 indexed citations

15.

Cox, Charles E., John V. Kiluk, Adam I. Riker, et al.. (2007). Significance of Sentinel Lymph Node Micrometastases in Human Breast Cancer. Journal of the American College of Surgeons. 206(2). 261–268. 99 indexed citations

16.

Pilon‐Thomas, Shari, et al.. (2006). Immunostimulatory Effects of CpG-ODN Upon Dendritic Cell-Based Immunotherapy in a Murine Melanoma Model. Journal of Immunotherapy. 29(4). 381–387. 41 indexed citations

17.

Poole, I. Caroline Le, Adam I. Riker, Lawrence Stennett, et al.. (2002). Interferon-γ Reduces Melanosomal Antigen Expression and Recognition of Melanoma Cells by Cytotoxic T Cells. American Journal Of Pathology. 160(2). 521–528. 43 indexed citations

18.

Ohnmacht, Galen A., Ena Wang, Simone Mocellin, et al.. (2001). Short-Term Kinetics of Tumor Antigen Expression in Response to Vaccination. The Journal of Immunology. 167(3). 1809–1820. 69 indexed citations

19.

Riker, Adam I., Monica C. Panelli, Udai S. Kammula, et al.. (1999). Development and Characterization of Melanoma Cell Lines Established by Fine-Needle Aspiration Biopsy: Advances in the Monitoring of Patients with Metastatic Melanoma. Cancer Detection and Prevention. 23(5). 387–396. 26 indexed citations

20.

Riker, Adam I., Steven K. Libutti, & David L. Bartlett. (1997). Advances in the early detection, diagnosis, and staging of pancreatic cancer. Surgical Oncology. 6(3). 157–169. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact